SANOFICONRPharmaceuticals
Sanofi Consumer Healthcare Inc — Profit & Loss Statement
₹4298.20
-3.13%
Sanofi Consumer Healthcare Inc Profit & Loss Statement (Annual)
| Metric | 2024 | 2023 |
|---|---|---|
| Tax Effect Of Unusual Items | -7.57 Cr | -0.45 Cr |
| Tax Rate For Calcs | 0.27 | 0.25 |
| Normalized EBITDA | 283.70 Cr | 223.10 Cr |
| Total Unusual Items | -28.40 Cr | -1.80 Cr |
| Total Unusual Items Excluding Goodwill | -28.40 Cr | -1.80 Cr |
| Net Income From Continuing Operation Net Minority Interest | 181.00 Cr | 164.90 Cr |
| Reconciled Depreciation | 4.50 Cr | 1.80 Cr |
| Reconciled Cost Of Revenue | 228.80 Cr | 194.00 Cr |
| EBITDA | 255.30 Cr | 221.30 Cr |
| EBIT | 250.80 Cr | 219.50 Cr |
| Net Interest Income | 7.80 Cr | 3.80 Cr |
| Interest Expense | 4.00 Cr | 0.20 Cr |
| Interest Income | 10.90 Cr | 4.00 Cr |
| Normalized Income | 201.83 Cr | 166.25 Cr |
| Net Income From Continuing And Discontinued Operation | 181.00 Cr | 164.90 Cr |
| Total Expenses | 450.00 Cr | 327.10 Cr |
| Rent Expense Supplemental | 2.70 Cr | 0.20 Cr |
| Diluted Average Shares | 2.30 Cr | 2.30 Cr |
| Basic Average Shares | 2.30 Cr | 2.30 Cr |
| Diluted EPS | 78.59 | 71.60 |
| Basic EPS | 78.59 | 71.60 |
| Diluted NI Availto Com Stockholders | 181.00 Cr | 164.90 Cr |
| Net Income Common Stockholders | 181.00 Cr | 164.90 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 |
| Net Income | 181.00 Cr | 164.90 Cr |
| Net Income Including Noncontrolling Interests | 181.00 Cr | 164.90 Cr |
| Net Income Continuous Operations | 181.00 Cr | 164.90 Cr |
| Tax Provision | 65.80 Cr | 54.40 Cr |
| Pretax Income | 246.80 Cr | 219.30 Cr |
| Other Non Operating Income Expenses | 1.10 Cr | 0.10 Cr |
| Special Income Charges | -28.40 Cr | -1.80 Cr |
| Other Special Charges | 7.70 Cr | — |
| Write Off | 10.80 Cr | — |
| Impairment Of Capital Assets | 2.90 Cr | — |
| Restructuring And Mergern Acquisition | 7.00 Cr | 1.80 Cr |
| Net Non Operating Interest Income Expense | 7.80 Cr | 3.80 Cr |
| Total Other Finance Cost | -0.90 Cr | — |
| Interest Expense Non Operating | 4.00 Cr | 0.20 Cr |
| Interest Income Non Operating | 10.90 Cr | 4.00 Cr |
| Operating Income | 266.20 Cr | 217.20 Cr |
| Operating Expense | 221.20 Cr | 133.10 Cr |
| Other Operating Expenses | 47.20 Cr | 23.10 Cr |
| Depreciation And Amortization In Income Statement | 4.50 Cr | 1.80 Cr |
| Amortization | 1.00 Cr | 0.70 Cr |
| Depreciation Income Statement | 3.50 Cr | 1.10 Cr |
| Selling General And Administration | 72.40 Cr | 64.70 Cr |
| Selling And Marketing Expense | 57.20 Cr | 58.50 Cr |
| General And Administrative Expense | 15.20 Cr | 6.20 Cr |
| Rent And Landing Fees | 2.70 Cr | 0.20 Cr |
| Gross Profit | 487.40 Cr | 350.30 Cr |
| Cost Of Revenue | 228.80 Cr | 194.00 Cr |
| Total Revenue | 716.20 Cr | 544.30 Cr |
| Operating Revenue | 716.20 Cr | 544.30 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sanofi Consumer Healthcare Inc
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.